These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines. Fauconnier A EMBO Rep; 2017 Feb; 18(2):198-200. PubMed ID: 28082313 [TBL] [Abstract][Full Text] [Related]
23. Pitfalls of Personalizing Cancer Treatment. Perez K Am J Clin Oncol; 2016 Feb; 39(1):107. PubMed ID: 26785382 [No Abstract] [Full Text] [Related]
24. Is Personalized Medicine Here? Carneiro BA; Costa R; Taxter T; Chandra S; Chae YK; Cristofanilli M; Giles FJ Oncology (Williston Park); 2016 Apr; 30(4):293-303, 307. PubMed ID: 27085327 [TBL] [Abstract][Full Text] [Related]
25. Personalized Devices Predict Cancer Drug Sensitivity In Vivo. Balakrishnan VS J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26340999 [No Abstract] [Full Text] [Related]
26. Precision medicine initiative. Porche DJ Am J Mens Health; 2015 May; 9(3):177. PubMed ID: 25759367 [No Abstract] [Full Text] [Related]
27. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers. Saumet A; Lecellier CH Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176 [TBL] [Abstract][Full Text] [Related]
28. Special Issue "From Basic Science to Treatment Strategies: Personalized Cancer Therapy". Muminovic M; Hussein A; Raez LE Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338712 [TBL] [Abstract][Full Text] [Related]
29. Precision oncology: a strategy we were not ready to deploy. Fojo T Semin Oncol; 2016 Feb; 43(1):9-12. PubMed ID: 26970119 [No Abstract] [Full Text] [Related]
30. [Pathology in the era of personlized medicine]. Liu TH Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):217-8. PubMed ID: 18844027 [No Abstract] [Full Text] [Related]
31. Strides in personalized medicine. Printz C Cancer; 2012 Dec; 118(23):5722-3. PubMed ID: 23165699 [No Abstract] [Full Text] [Related]
33. Lack of access to targeted cancer therapy. Burki TK Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211 [No Abstract] [Full Text] [Related]
34. 'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems. Crommelin DJ; Storm G; Luijten P Int J Pharm; 2011 Aug; 415(1-2):5-8. PubMed ID: 21320581 [TBL] [Abstract][Full Text] [Related]
35. Next-Generation Sequencing in Oncology in the Era of Precision Medicine. Blumenthal GM; Mansfield E; Pazdur R JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172 [No Abstract] [Full Text] [Related]
36. Are there any differences in the regulations of personalized medicine among the USA, EU and Japan? Shimazawa R; Ikeda M Br J Clin Pharmacol; 2013 May; 75(5):1365-7. PubMed ID: 22978372 [No Abstract] [Full Text] [Related]
37. Cancer research: in need of introspection. Jalali R; Mittra I; Badwe R Lancet Oncol; 2016 Feb; 17(2):140-141. PubMed ID: 26868338 [No Abstract] [Full Text] [Related]
38. The pseudo-high-risk prevention strategy. Chiolero A; Paradis G; Paccaud F Int J Epidemiol; 2015 Oct; 44(5):1469-73. PubMed ID: 26071137 [No Abstract] [Full Text] [Related]
39. Personalized medicine: a windfall for science, but what about patients? Browman G; Hébert PC; Coutts J; Stanbrook MB; Flegel K; MacDonald NE CMAJ; 2011 Dec; 183(18):E1277. PubMed ID: 21768249 [No Abstract] [Full Text] [Related]
40. Standardization of generic pre-analytical procedures for in vitro diagnostics for personalized medicine. Oelmueller U N Biotechnol; 2021 Jan; 60():1. PubMed ID: 32750427 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]